Futreal PA - Search Results

1

Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.

Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, Ghadirian P, Perret C, Moslehi R, Dion F, Faucher MC, Dole K, Karimi S, Foulkes W, Lounis H, Warner E, Goss P, Anderson D, Larsson C, Narod SA, Futreal PA. Phelan CM, et al. Among authors: futreal pa. Nat Genet. 1996 May;13(1):120-2. doi: 10.1038/ng0596-120. Nat Genet. 1996. PMID: 8673090

2

BRCA2 mutations in primary breast and ovarian cancers.

Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR, Futreal PA. Lancaster JM, et al. Among authors: futreal pa. Nat Genet. 1996 Jun;13(2):238-40. doi: 10.1038/ng0696-238. Nat Genet. 1996. PMID: 8640235

3

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

Tonin PN, Mes-Masson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DE, Provencher D, Ghadirian P, Narod SA. Tonin PN, et al. Among authors: futreal pa. Am J Hum Genet. 1998 Nov;63(5):1341-51. doi: 10.1086/302099. Am J Hum Genet. 1998. PMID: 9792861 Free PMC article.

4

Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes.

Brunet JS, Ghadirian P, Rebbeck TR, Lerman C, Garber JE, Tonin PN, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade OI, Moslehi R, Liede A, Futreal PA, Weber BL, Lenoir GM, Lynch HT, Narod SA. Brunet JS, et al. Among authors: futreal pa. J Natl Cancer Inst. 1998 May 20;90(10):761-6. doi: 10.1093/jnci/90.10.761. J Natl Cancer Inst. 1998. PMID: 9605646

5

BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1.

Lancaster JM, Carney ME, Gray J, Myring J, Gumbs C, Sampson J, Wheeler D, France E, Wiseman R, Harper P, Futreal PA. Lancaster JM, et al. Among authors: futreal pa. Br J Cancer. 1998 Dec;78(11):1417-20. doi: 10.1038/bjc.1998.701. Br J Cancer. 1998. PMID: 9836472 Free PMC article.

6

The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumors.

Phelan CM, Larsson C, Baird S, Futreal PA, Ruttledge MH, Morgan K, Tonin P, Hung H, Korneluk RG, Pollak MN, Narod SA. Phelan CM, et al. Among authors: futreal pa. Genomics. 1996 May 15;34(1):63-8. doi: 10.1006/geno.1996.0241. Genomics. 1996. PMID: 8661024

7

Dideoxy fingerprinting assay for BRCA1 mutation analysis.

Lancaster JM, Berchuck A, Futreal PA, Wiseman RW. Lancaster JM, et al. Among authors: futreal pa. Mol Carcinog. 1997 Jul;19(3):176-9. Mol Carcinog. 1997. PMID: 9254884

8

Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.

Futreal PA, Cochran C, Marks JR, Iglehart JD, Zimmerman W, Barrett JC, Wiseman RW. Futreal PA, et al. Cancer Res. 1994 Apr 1;54(7):1791-4. Cancer Res. 1994. PMID: 7511052

9

Detection of BRCA1 mutations in women with early-onset ovarian cancer by use of the protein truncation test.

Lancaster JM, Cochran CJ, Brownlee HA, Evans AC, Berchuck A, Futreal PA, Wiseman RW. Lancaster JM, et al. Among authors: futreal pa. J Natl Cancer Inst. 1996 Apr 17;88(8):552-4. doi: 10.1093/jnci/88.8.552. J Natl Cancer Inst. 1996. PMID: 8606385 No abstract available.

10

Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers.

Carney ME, Maxwell GL, Lancaster JM, Gumbs C, Marks J, Berchuck A, Futreal PA. Carney ME, et al. Among authors: futreal pa. J Soc Gynecol Investig. 1998 Sep-Oct;5(5):281-5. doi: 10.1016/s1071-5576(98)00018-5. J Soc Gynecol Investig. 1998. PMID: 9773405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

352 results

Search Page